Neuphoria Therapeutics Inc.
NEUPHealthcare|Biotechnology|US
$2.78
+0.01 (+0.36%)
DCF Value
$3103.96
Tangible Book / Share
$3.13
Cash / Share
$3.67
Analyst Consensus
Buy2 analysts
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
Consensus Target
$7.00
Implied Upside
+151.8%
Low Target
$7.00
High Target
$7.00
Price Target Trend
Last Month
—
0 targets
Last Quarter
—
0 targets
Last Year
$7.00
1 target · +152% vs price
All Time
$7.00
1 target · +152% vs price
Rating Trend
Dec 25
2 buy · 1 hold · 0 sell
Jan 26
2 buy · 1 hold · 0 sell
Feb 26
2 buy · 1 hold · 0 sell
Mar 26
2 buy · 1 hold · 0 sell
Apr 26
2 buy · 0 hold · 0 sell
May 26
2 buy · 1 hold · 0 sell
Jun 26
2 buy · 1 hold · 0 sell
Jul 26
0 buy · 1 hold · 0 sell
Aug 26
0 buy · 1 hold · 0 sell
Sep 26
0 buy · 1 hold · 0 sell
Oct 26
0 buy · 1 hold · 0 sell
Nov 26
0 buy · 1 hold · 0 sell
Recent Price Targets
| Date | Firm | Analyst | Target | Price Then | Source |
|---|---|---|---|---|---|
| Dec 5, 2025 | H.C. Wainwright | $7.00(+64%) | $4.27 | TheFly |
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| HC Wainwright & Co. | downgrade | Buy →Neutral | May 15, 2026 |
| HC Wainwright & Co. | maintain | Buy | Dec 5, 2025 |
| Maxim Group | maintain | Buy | Sep 11, 2025 |
| HC Wainwright & Co. | maintain | Buy | Aug 26, 2025 |
| HC Wainwright & Co. | maintain | Buy | Feb 4, 2025 |
Earnings History
| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Sep 18, 2026 | $-0.56 | $-0.56 | $1.2M | $996.5K |
| Sep 2, 2026 | $-0.56 | $-0.56 | $1.2M | $1.2M |
| May 15, 2026 | $-0.09 | $-0.56 | — | — |
| Feb 17, 2026 | $-0.77 | $-0.56 | — | — |
| Nov 14, 2025 | $-4.41 | $-1.33 | — | — |
| Sep 29, 2025 | $-5.79 | $-0.56 | -$6.5K | $15.0M |
| May 20, 2025 | $-1.26 | $-0.47 | $7.5M | $15.0M |
| Mar 17, 2025 | $-1.23 | $-0.47 | $663.0K | $15.0M |